top of page

CONTINUUS awarded SBIR Phase II grant from the NSF

Tuesday, March 1st, 2016 - General News

CONTINUUS Pharmaceuticals was awarded a Phase II SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase II grant consists of $750,000 over a two year period, with the opportunity for additional matching funds to facilitate commercial partnerships.

Recent Posts

See All

CONTINUUS ON SHOW AT CHPI 2022

Monday, September 26th, 2022 - General News CPHI 2022 is just around the corner and CONTINUUS is pleased to be part of it! From November...

Comments


Contact Us

25 Olympia Ave, Woburn,

MA 01801, USA

  • LinkedIn
  • Youtube
  • Twitter
bottom of page